Medscape Cardiology: Leading the Future of Heart Failure Education at HFSA 2025
August 22, 2025 | Cardiology Education, HF Education, HFSA2025, Innovation, Research Hub, heart failure, sponsorship
Medscape Cardiology | theheart.org is proud to be at the forefront of the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM), September 26–29, 2025, in Minneapolis, MN! With clinicians and patient care top of mind, we are driving innovation in heart failure education through dynamic symposia, groundbreaking research, and our presence on the exhibit floor.
This year, we are raising the bar by sponsoring the HFSA Research Hub, supporting the most exciting advances in science and practice directly to the community of cardiology leaders who are shaping the future of health care.
Why It Matters
HFSA ASM is where the brightest minds in cardiology gather to share breakthroughs and shape the future of heart failure care. Medscape is proud to power this exchange with accessible, evidence-based education that transforms discovery into better outcomes for patients.
What we have in store for HFSA 2025
At Medscape, innovation isn’t just a buzzword; it’s our blueprint. From symposia that spark game-changing conversations to immersive hubs that showcase the next frontier of medicine, here’s what you won’t want to miss:
Must-Attend Symposia
Game-Changing Developments in Hypertrophic Cardiomyopathy: Rapid-Fire Insights
Friday, September 26 | 8:00–9:30 PM CT | 📍 Hilton Minneapolis – Grand Ballroom G |🔗 Register Here
Revolutionizing Heart Failure Management: Nonsteroidal Mineralocorticoid Receptor Antagonists (nsMRAs) in Focus
Sunday, September 28 | 5:30–7:00 PM CT | 📍 Hilton Minneapolis – Grand Ballroom D | 🔗 Register Here
🔬 Research Hub Sponsorship (Sept 26-28) | Exhibit Hall
As a leading innovator in CME, we are dedicated to empowering healthcare professionals with the knowledge and tools needed to advance patient care in heart failure. That’s why this year we have sponsored the HFSA Research Hub!
Step inside the Research Hub for bold conversations and cutting-edge science that’s reshaping heart failure care. This is more than lectures; it’s an interactive forum where discovery meets practice. Engage with experts, challenge ideas, and gain a front-row seat to the innovations that will define tomorrow’s care.
📍 Visit Us at Booth #318
Our 10×20 Medscape Cardiology | theheart.org booth is your destination for transformative education. Learn how our tailored CME solutions enhance expertise, elevate clinical practice, and, most importantly, improve outcomes for patients living with heart failure.
✨ Be part of the hunt! Download the ASM mobile app, stop by our booth, and climb the leaderboard for a chance to win a prize through HFSA.
📚 Heart Failure Expertise: Publications at HFSA
As the trusted voice in accredited CME, Medscape is committed to equipping clinicians with the insights and innovations that drive better patient care in heart failure. Don’t miss our latest contributions to advancing education and practice:
- Enhancing Nursing Knowledge and Competencies in Hypertrophic Cardiomyopathy: Impact of a Webinar-Based CME Intervention (Authors: Margaret Harris, PhD; Julie Schrand; Asha Gupta, PharmD)
- Hypertrophic Cardiomyopathy Gameshow Improves Physician Knowledge and Confidence (Authors: Margaret Harris, PhD; Julie Schrand; George Boutsalis, PhD)
Let’s Shape the Future—Together
At HFSA 2025, we invite you to join us, connect, and explore new ways to empower clinicians, strengthen patient care, and transform outcomes. See you in Minneapolis!
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Medscape Education Receives Joint Accreditation with Commendation to Deliver Continuing Education for Healthcare Providers
Medscape Education has been awarded Accreditation with Commendation, the highest designation possible by the Joint Accreditation for Interprofessional Continuing Education™, ensuring quality accredited continuing education for members of the healthcare...
Abstract Highlights from EHA 2022 : A Spotlight on CLL
Spotlight on CLLAhead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Prof John Gribben, UK, on the most important abstracts to look out for in...
Abstract Highlights from EHA 2022 : A Spotlight on Lymphoma
Spotlight on LymphomaAhead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Dr Loretta Nastoupil, US, on the most important abstracts to look out for in...
TECHNOLOGY TRENDS AND THE FUTURE OF MEDICAL DEVICES
A MEDSCAPE DIGITAL HEALTH AND INNOVATION EVENT
Device Technology and Innovations
The world of medical device technology is constantly evolving. From wearable devices to diagnostic technology, clinicians have more options than ever for monitoring and assessing their patients' health. The accessibility...
The Power of AI in Medical Education
Artificial intelligence (AI) is a rapidly growing field with many applications in the world of medicine, including continuing medical education. Ritu Kumar, Medscape lead data scientist, explains how Medscape Education...
Connect to the conversation around mental health: A spotlight on physician burnout
For more than 2 years, the COVID-19 pandemic has put emphasis on an issue that has long affected healthcare workers and physicians -- burnout. Every year, Medscape surveys thousands of...
MEDSCAPE EDUCATION: The Human Story in Virtual Patient Simulation
WHAT'S THE STORYStories are shared experiences, where meaning-centered approaches and coping strategies ascribe cultural meaningto events and emotions; a way to merge the individual and the collective experience into the...
It’s a Medscape wrap for EHA2022
EHA2022 Hybrid Congress has now come to a close with the Thematic Days finishing last week. The Medscape team were delighted to connect with so many physicians, colleagues and supporters...
Part 4 of 4, of the Medscape video interview series
Dr. Hansa Bhargava MD interviews Dr. Maria Victoria Mateos on the most important abstracts to look out for in multiple myeloma and the potential implications of these data for managing patients...